Bicara Therapeutics Inc. Common Stock
(BCAX - NASDAQ)
22,48 USD
📋 Profilo Aziendale

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors.

|